skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Springer Nature - Springer Journals All 2022 remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk
A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk
Material Type:
Artigo 		Adicionar ao Meu Espaço

A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk

Garate, David ; Thang, Christopher J. ; Golovko, George ; Wilkerson, Michael G. ; Barbieri, John S.

Archives of dermatological research, 2024-05, Vol.316 (5), p.196-196, Article 196 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
2
Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni
Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni
Material Type:
Artigo 		Adicionar ao Meu Espaço

Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni

Mohammad, Omnia Sobhi ; Hussein, Hesham Mohammed ; Abdel-Sayed, Samia William ; Mohamed, Ghada Adel ; Shehata, Mai Abdel Sameaa

Parasitology research (1987), 2024-05, Vol.123 (5), p.215-215, Article 215 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
3
Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability
Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability

Kelidari, H. R. ; Saeedi, M. ; Akbari, J. ; Morteza-semnani, K. ; Valizadeh, H. ; Maniruzzaman, Mohammed ; Farmoudeh, Ali ; Nokhodchi, Ali

AAPS PharmSciTech, 2017-07, Vol.18 (5), p.1469-1474 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
4
Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes

Dong, Dan ; Fan, Ting-ting ; Ji, Ying-shi ; Yu, Jin-yu ; Wu, Shan ; Zhang, Li

International urology and nephrology, 2019-04, Vol.51 (4), p.755-764 [Periódico revisado por pares]

Dordrecht: Springer Netherlands

Texto completo disponível

Citações Citado por
5
Pharmacokinetics of oral spironolactone in infants up to 2 years of age
Pharmacokinetics of oral spironolactone in infants up to 2 years of age
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetics of oral spironolactone in infants up to 2 years of age

Lass, Jana ; Leroux, Stephanie ; Kõrgvee, Lenne-Triin ; Varendi, Heili ; Kipper, Karin ; Takkis, Kalev ; Aro, Rudolf ; Metsvaht, Tuuli ; Oselin, Kersti ; Pfister, Marc ; Soeorg, Hiie ; van den Anker, Johannes ; Lutsar, Irja

European journal of clinical pharmacology, 2024-02, Vol.80 (2), p.239-248 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
6
Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study
Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of spironolactone and sitagliptin improves clinical outcomes of outpatients with COVID-19: a prospective cohort study

Davarpanah, M. A. ; Adatorwovor, R. ; Mansoori, Y. ; Ramsheh, F. S. R. ; Parsa, A. ; Hajiani, M. ; Faramarzi, H. ; Kavuluru, R. ; Asadipooya, K.

Journal of endocrinological investigation, 2024-01, Vol.47 (1), p.235-243 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
7
Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials
Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials

Yang, Pingping ; Shen, Wen ; Chen, Xi ; Zhu, Dan ; Xu, Xiuxiu ; Wu, Tao ; Xu, Gaosi ; Wu, Qinghua

Heart failure reviews, 2019-09, Vol.24 (5), p.637-646 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
8
Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial

Kato, Sawako ; Maruyama, Shoichi ; Makino, Hirofumi ; Wada, Jun ; Ogawa, Daisuke ; Uzu, Takashi ; Araki, Hisazumi ; Koya, Daisuke ; Kanasaki, Keizo ; Oiso, Yutaka ; Goto, Motomitsu ; Nishiyama, Akira ; Kobori, Hiroyuki ; Imai, Enyu ; Ando, Masahiko ; Matsuo, Seiichi

Clinical and experimental nephrology, 2015-12, Vol.19 (6), p.1098-1106 [Periódico revisado por pares]

Tokyo: Springer Japan

Texto completo disponível

Citações Citado por
9
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies

Rozner, Raquel N. ; Freites-Martinez, Azael ; Shapiro, Jerry ; Geer, Eliza B. ; Goldfarb, Shari ; Lacouture, Mario E.

Breast cancer research and treatment, 2019-02, Vol.174 (1), p.15-26 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
10
Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect
Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect
Material Type:
Artigo 		Adicionar ao Meu Espaço

Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect

Ferreira, João Pedro ; Girerd, Nicolas ; Medeiros, Pedro Bettencourt ; Santos, Mário ; Carvalho, Henrique Cyrne ; Bettencourt, Paulo ; Kénizou, David ; Butler, Javed ; Zannad, Faiez ; Rossignol, Patrick

Clinical research in cardiology, 2016-06, Vol.105 (6), p.489-507 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (381)

Data de Publicação 

De até
Refinar
  1. Antes de1978  (40)
  2. 1978Até1989  (34)
  3. 1990Até2001  (42)
  4. 2002Até2013  (146)
  5. Após 2013  (137)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (368)
  2. Japonês  (34)
  3. Alemão  (29)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.